-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Panacea Life Sciences Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2015 to Q1 2024.
- Panacea Life Sciences Holdings, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$357K, a 13.8% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$1.52M, a 36.5% increase from 2022.
- Panacea Life Sciences Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$2.4M, a 38.8% increase from 2021.
- Panacea Life Sciences Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$3.92M, a 48.7% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)